Crop Solutions Provider Arysta LifeScience to be acquired by Platform Specialty Products

Platform Specialty Products, the chemical maker said that it had agreed to buy a privately held life science and crop protection company, Arysta LifeScience, for about $3.5 billion. This deal is expected to boost Platform Specialty’s offerings of nontraditional and traditional methods for protecting crops, including herbicides and insecticides. This year, Platform Specialty also agreed […]

CSR to be acquired by World’s Largest Mobile Chipmaker Qualcomm

The American wireless technology company, Qualcomm, which is one of the world’s biggest chipmakers, has agreed to acquire CSR, the British chipmaker for approximately $2.5 billion or 1.6 billion pounds. For CSR, who is a pioneer in Bluetooth wireless technology, this deal comes as many of the world’s largest chipmakers seek to take advantage of […]

New Britain Palm Oil Ltd Receives a Takeover Bid by Sime Darby Berhad

In a move to expand its plantation business, Sime Darby Berhad has made an offer to acquire all of the shares in New Britain Palm Oil Ltd which has plantations in Papua New Guinea for £1.073 billion. The conglomerate said that its unit Sime Darby Plantation “intends to make a cash offer to acquire all […]

Medical Technology Corporation CareFusion to be acquired by Becton Dickinson

Becton, Dickinson & Company said that for $12.2 billion in stock and cash it would purchase CareFusion, which provides services and products to hospitals. Becton Dickinson will pay $58 per share for CareFusion, most of that in cash, which is 26 percent above CareFusion’s closing price on Friday. Combining CareFusion and Becton Dickinson will create […]

Alios BioPharma to be acquired by Johnson & Johnson for $1.75 Billion

Johnson & Johnson said that it is going to purchase Alios BioPharma which is a private biotechnology company for $1.75 billion in cash. Alios BioPharma is developing a treatment for respiratory syncytial virus, which is known as RSV. Presently, the drug is in phase 2 studies. The head of research and development at Janssen Pharmaceutical […]